Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
10
2016
Two New TTB Rulings Issued on General Use Formulas McDermott Will & Emery
Oct
10
2016
Difficulties with Setting Level of THC Impairedness for Drivers Rosenfeld Injury Lawyers
Oct
8
2016
The Week Ahead in the European Parliament – October 7, 2016: Agricultural and Rural Development; International Trade, Comprehensive Economic and Trade Agreement, JURI Covington & Burling LLP
Oct
7
2016
Massachusetts State Court Rejects Medical Marijuana Suit Jackson Lewis P.C.
Oct
7
2016
EU Tackles Acrylamide Keller and Heckman LLP
Oct
7
2016
EU Policy Update, October 2016: Brexit and the EU’s Response; Communication and Media Policies; Energy and Climate Change Policies; Trade Policy and Sanctions Covington & Burling LLP
Oct
6
2016
FDA Issues Updated Manufactured Food Regulatory Program Standards Keller and Heckman LLP
Oct
5
2016
WHO Chief Calls on Consumers to Choose “Antibiotic-Free” Meat Keller and Heckman LLP
Oct
5
2016
Judge Grants Gilead Motion To Invalidate Remicade Patent For Obviousness-Type Double Patenting Foley & Lardner LLP
Oct
4
2016
FDA Adds Six More Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Oct
4
2016
FDA Finalizes Rule Governing Establishment Registration and Listing for Human Drugs McDermott Will & Emery
Oct
4
2016
Food Industry Generally Supports Extending POS Signage for Calif. Prop 65 BPA Warnings Keller and Heckman LLP
Oct
4
2016
10 Key Takeaways from FDA’s Draft Guidance on 510(k) Modifications Morgan, Lewis & Bockius LLP
Oct
4
2016
FDA Will Exercise Enforcement Discretion for “Healthy” Food Claims Morgan, Lewis & Bockius LLP
Oct
3
2016
FDA to Redefine “Healthy” Claim for Food Labeling McDermott Will & Emery
Oct
3
2016
Food Safety and Inspection Service Requests Comments on Labeling Guidance for Animal Raising Claims Keller and Heckman LLP
Oct
3
2016
FDA Chemical Regulation: Anti-Anti-Bacterials? ArentFox Schiff LLP
Oct
3
2016
Ukraine’s Competition Authority Issues Major Decision on Drug Pricing Practices Michael Best & Friedrich LLP
Sep
30
2016
China's General Rules for Food Production Licensing Review Take Effect Keller and Heckman LLP
Sep
30
2016
Industry Guidance on Unapproved or Off-Label Information Provides Insight Into Issues Under FDA Review Covington & Burling LLP
Sep
29
2016
FDA Issues Draft Guidance on Risk Evaluation and Mitigation Strategy (REMS) Determinations McDermott Will & Emery
Sep
29
2016
Fruit Labeling Accuracy Act of 2016 Would Prohibit Added Sugars Labeling for Naturally Tart Fruits Keller and Heckman LLP
Sep
28
2016
International Organization for Standardization Publishes Standard for Compilation and Description of Sample Preparation and Dosing Methods for Engineered and Manufactured Nanomaterials Bergeson & Campbell, P.C.
Sep
28
2016
FDA Updates Food Facility Registration Product Categories Keller and Heckman LLP
Sep
28
2016
French Pilot on Mandatory Country of Origin Labelling (COOL) for Dairy and Meat in Processed Foods Covington & Burling LLP
Sep
27
2016
The Hullabaloo about Healthy: FDA Formally Seeks to Redefine “Healthy” Keller and Heckman LLP
Sep
27
2016
FDA Holding its First Public Meeting on Drug Product Identification Requirements in October Mintz
Sep
27
2016
Drug Company Accused of Price-Gouging Has Developed Deep Capitol Network Since 2010 MapLight
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins